Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells
Top Cited Papers
- 1 May 2004
- journal article
- case report
- Published by Elsevier in The Lancet
- Vol. 363 (9419), 1439-1441
- https://doi.org/10.1016/s0140-6736(04)16104-7
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primatesBlood, 2003
- Mesenchymal Stem Cells Inhibit and Stimulate Mixed Lymphocyte Cultures and Mitogenic Responses Independently of the Major Histocompatibility ComplexScandinavian Journal of Immunology, 2003
- The significance of graft-versus-host disease and pretransplantation minimal residual disease status to outcome after allogeneic stem cell transplantation in patients with acute lymphoblastic leukemiaBlood, 2001
- Rapid Hematopoietic Recovery After Coinfusion of Autologous-Blood Stem Cells and Culture-Expanded Marrow Mesenchymal Stem Cells in Advanced Breast Cancer Patients Receiving High-Dose ChemotherapyJournal of Clinical Oncology, 2000